[CUE] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
03-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 16.53%
YoY- -1.16%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 2,658 1,717 1,821 2,100 1,382 187 151 577.86%
PBT -10,171 -12,347 -13,434 -11,005 -13,185 -13,109 -14,592 -21.40%
Tax 0 806 807 700 564 99 -138 -
NP -10,171 -12,347 -13,434 -11,005 -13,185 -13,208 -14,454 -20.90%
Tax Rate - - - - - - - -
Total Cost 12,829 14,064 15,255 13,105 14,567 13,395 14,605 -8.28%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -382.66 -719.10 -737.73 -524.05 -954.05 -7,063.10 -9,557.79 -88.31%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.20 -0.25 -0.28 -0.24 -0.29 -0.30 -0.37 -33.66%
EPS Diluted -0.20 -0.25 -0.28 -0.24 -0.29 -0.30 -0.37 -33.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.